HCW Biologics Inc. (HCWB) stock
HCWBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/3095% below fair value
$0.76−0.01 (-1.65%)
Close on Nov 18, 2026Market cap $1.40MP/E –Yield –
HCW Biologics total assets
Total assets on the balance sheet at the end of each period.
HCW Biologics's total assets was $26.77M at Jun 30, 2026. For fiscal 2025 it was $24.52M, down 18.9% from the year before. The highest annual figure on record is $53.51M in fiscal 2021.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $24.52M | -18.9% |
| FY2024 | Dec 31, 2024 | $30.24M | +6.0% |
| FY2023 | Dec 31, 2023 | $28.51M | -39.1% |
| FY2022 | Dec 31, 2022 | $46.81M | -12.5% |
| FY2021 | Dec 31, 2021 | $53.51M | +247.5% |
| FY2020 | Dec 31, 2020 | $15.40M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $26.77M | -7.4% |
| Q1 FY2026 | Mar 31, 2026 | $27.34M | +4.0% |
| Q4 FY2025 | Dec 31, 2025 | $24.52M | -18.9% |
| Q3 FY2025 | Sep 30, 2025 | $25.45M | -4.2% |
| Q2 FY2025 | Jun 30, 2025 | $28.91M | +7.8% |
| Q1 FY2025 | Mar 31, 2025 | $26.29M | -13.6% |
| Q4 FY2024 | Dec 31, 2024 | $30.24M | +6.0% |
| Q3 FY2024 | Sep 30, 2024 | $26.56M | -25.4% |
| Q2 FY2024 | Jun 30, 2024 | $26.82M | -32.1% |
| Q1 FY2024 | Mar 31, 2024 | $30.43M | -30.1% |
| Q4 FY2023 | Dec 31, 2023 | $28.51M | -39.1% |
| Q3 FY2023 | Sep 30, 2023 | $35.62M | -30.6% |
| Q2 FY2023 | Jun 30, 2023 | $39.48M | -16.7% |
| Q1 FY2023 | Mar 31, 2023 | $43.53M | -14.6% |
| Q4 FY2022 | Dec 31, 2022 | $46.81M | -12.5% |
| Q3 FY2022 | Sep 30, 2022 | $51.35M | -9.0% |
| Q2 FY2022 | Jun 30, 2022 | $47.41M | +263.7% |
| Q1 FY2022 | Mar 31, 2022 | $50.96M | +230.9% |
| Q4 FY2021 | Dec 31, 2021 | $53.51M | – |
| Q3 FY2021 | Sep 30, 2021 | $56.41M | – |
| Q2 FY2021 | Jun 30, 2021 | $13.03M | – |
| Q4 FY2020 | Dec 31, 2020 | $15.40M | – |
See a number that looks wrong?